Search

Search Constraints

You searched for: Author/Creator Spazzapan, Simon

Search Results

1. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Issue 10374 (4th February 2023)

2. Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials. Issue 7 (1st March 2023)

3. First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study. (June 2021)

4. Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials. Issue 7 (July 2015)

6. Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial. Issue 1 (January 2018)

7. Retreatment with Trastuzumab after Progression on Lapatinib-Based Therapy in Heavily Pretreated HER2-Positive Metastatic Breast Cancer: A Single-Institution Experience. Issue 6 (November 2014)

8. Ten daily fractions for partial breast irradiation. Long‐term results of a prospective phase II trial. Issue 2 (3rd February 2019)